The most widely accepted classification for endoscopic stigmata is the Forrest classification, which divides endoscopically visible lesions into 3 classes (ie, I, II, and III). The classification is most useful because it is based on risk of rebleeding in the absence of endoscopic therapy. But how good are we at identifying/classifying the stigmata on endoscopy? Data from the REASON Registry from Canada, which reviewed endoscopy data retrospectively, showed that high-risk stigmata were present in 47.8% of the patients on endoscopy, but less than two-thirds of these received endoscopic therapy.